Merck Faces Patent Lawsuit Over Easier-to-Use Keytruda April 25, 2025 By Damian Garde A biotech company is suing Merck & Co. over its easier-to-use version of its blockbuster cancer treatment Keytruda, alleging the...
Merck’s $8 Billion Cancer Vaccine Faces First US Jury Trial January 27, 2025 By Peter Blumberg Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine...
N.J. Court: Insurer Cannot Cite War Exclusion to Deny Coverage for NotPetya Attack February 23, 2022 By Chad Hemenway Last month the Superior Court of New Jersey ruled insurers cannot use a policy exclusion to avoid covering about $1.4...
Merck Cyberattack’s $1.3 Billion Question: Was It an Act of War? December 3, 2019 By David Voreacos, Katherine Chiglinsky and Riley Griffin By the time Deb Dellapena arrived for work at Merck & Co.’s 90-acre campus north of Philadelphia, there was a...
Merck Agrees to Settle Coppertone Class Action Suit September 28, 2012 Merck & Co has agreed to pay between $3 million and $10 million to settle a nearly decade old class-action...